A detailed history of Virtue Capital Management, LLC transactions in Cyto Dyn Inc. stock. As of the latest transaction made, Virtue Capital Management, LLC holds 45,000 shares of CYDY stock, worth $6,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,000
Holding current value
$6,300
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.16 - $0.26 $7,200 - $11,700
45,000 New
45,000 $7,000
Q3 2023

Nov 14, 2023

BUY
$0.18 - $0.28 $8,100 - $12,600
45,000 New
45,000 $8,000
Q3 2022

Nov 15, 2022

BUY
$0.39 - $1.23 $17,550 - $55,350
45,000 New
45,000 $19,000

Others Institutions Holding CYDY

About CytoDyn Inc.


  • Ticker CYDY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 813,040,000
  • Market Cap $114M
  • Description
  • CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...
More about CYDY
Track This Portfolio

Track Virtue Capital Management, LLC Portfolio

Follow Virtue Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtue Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtue Capital Management, LLC with notifications on news.